Wuhan Hvsen Biotechnology Unveils 2026 Employee Stock Ownership Scheme

Stock News02-05

Wuhan Hvsen Biotechnology Co.,Ltd. (300871.SZ) has disclosed a draft plan for its 2026 employee stock ownership scheme. The plan will involve no more than 14 participants, with total raised capital not exceeding 3.081 million yuan. The scheme uses "units" as the subscription measure, with each unit valued at 1.00 yuan, and the total number of units is capped at 3.081 million. The shares for the employee stock ownership plan will be sourced from the company's A-share common stock repurchased and held in a special securities account. After obtaining approval from the company's shareholders' meeting, the plan will acquire these company shares from the special repurchase account through methods permitted by laws and regulations, such as non-trading transfer. The total number of shares to be acquired under the employee stock ownership plan will not exceed 205,400 shares, representing 0.10% of the company's total share capital as of the announcement date of the draft plan.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1135340466?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-05 20:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1135340466","market":"fut","top_or_hot":-1,"title":"Wuhan Hvsen Biotechnology Unveils 2026 Employee Stock Ownership Scheme","media":"Stock News","content":"<p>Wuhan Hvsen Biotechnology Co.,Ltd. (300871.SZ) has disclosed a draft plan for its 2026 employee stock ownership scheme. The plan will involve no more than 14 participants, with total raised capital not exceeding 3.081 million yuan. The scheme uses \"units\" as the subscription measure, with each unit valued at 1.00 yuan, and the total number of units is capped at 3.081 million. The shares for the employee stock ownership plan will be sourced from the company's A-share common stock repurchased and held in a special securities account. After obtaining approval from the company's shareholders' meeting, the plan will acquire these company shares from the special repurchase account through methods permitted by laws and regulations, such as non-trading transfer. The total number of shares to be acquired under the employee stock ownership plan will not exceed 205,400 shares, representing 0.10% of the company's total share capital as of the announcement date of the draft plan.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wuhan Hvsen Biotechnology Unveils 2026 Employee Stock Ownership Scheme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWuhan Hvsen Biotechnology Unveils 2026 Employee Stock Ownership Scheme\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-02-05 20:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wuhan Hvsen Biotechnology Co.,Ltd. (300871.SZ) has disclosed a draft plan for its 2026 employee stock ownership scheme. The plan will involve no more than 14 participants, with total raised capital not exceeding 3.081 million yuan. The scheme uses \"units\" as the subscription measure, with each unit valued at 1.00 yuan, and the total number of units is capped at 3.081 million. The shares for the employee stock ownership plan will be sourced from the company's A-share common stock repurchased and held in a special securities account. After obtaining approval from the company's shareholders' meeting, the plan will acquire these company shares from the special repurchase account through methods permitted by laws and regulations, such as non-trading transfer. The total number of shares to be acquired under the employee stock ownership plan will not exceed 205,400 shares, representing 0.10% of the company's total share capital as of the announcement date of the draft plan.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"","article_id":"1135340466","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1135340466","pubTimestamp":1770294035,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Wuhan Hvsen Biotechnology Co.,Ltd. (300871.SZ) has disclosed a draft plan for its 2026 employee stock ownership scheme. The plan will involve no more than 14 participants, with total raised capital...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300871":"回盛生物","BK0239":"医药制造"},"translate_title":"武汉Hvsen生物科技公布2026年员工持股计划","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300871":1},"content_text":"Wuhan Hvsen Biotechnology Co.,Ltd. (300871.SZ) has disclosed a draft plan for its 2026 employee stock ownership scheme. The plan will involve no more than 14 participants, with total raised capital not exceeding 3.081 million yuan. The scheme uses \"units\" as the subscription measure, with each unit valued at 1.00 yuan, and the total number of units is capped at 3.081 million. The shares for the employee stock ownership plan will be sourced from the company's A-share common stock repurchased and held in a special securities account. After obtaining approval from the company's shareholders' meeting, the plan will acquire these company shares from the special repurchase account through methods permitted by laws and regulations, such as non-trading transfer. The total number of shares to be acquired under the employee stock ownership plan will not exceed 205,400 shares, representing 0.10% of the company's total share capital as of the announcement date of the draft plan.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1135340466","isCrawlerRequest":true}